资讯
Thrombin is a multifunctional serine protease that is involved not only in mediating the cleavage of fibrinogen to fibrin in the coagulation cascade but also in activating a variety of cell types, ...
Asahi Kasei Pharma begins phase III study of promising CIPN prevention therapy, Recomodulin to enhance treatment options worldwide: Chelmsford, Massachusetts Thursday, July 3, 202 ...
The screening of fragments is an alternative approach to high-throughput screening for the identification of leads for therapeutic targets. Fragment hits have been discovered using X-ray ...
A new study found that patients with hemophilia A could safely switch directly from emicizumab to Mim8 without a washout period, meaning they did not need to stop treatment before starting the new ...
CHELMSFORD, Mass. & NOVI, Mich. & DÜSSELDORF, Germany & TOKYO, July 02, 2025--Asahi Kasei Pharma has started trial drug administration in a Phase III study of ART-123 in Japan for CIPN.
Leeches might make you squirm, but these small, blood-sucking creatures are making a big comeback in modern medicine. Once a staple of ancient healing methods, leech therapy is now gaining renewed ...
▎药明康德编者按:截至6月27日,FDA旗下的药物评价和研究中心(CDER)已经批准了16款创新药,其中小分子药物占比约60%。作为创新的赋能者、客户信赖的合作伙伴以及全球医药以及全球健康产业的贡献者,药明康德将持续通过独特的“CRDMO”业务模式, ...
Mutations in EGLN1, the gene encoding for hypoxia-inducible factor (HIF) prolyl-4-hydroxylase 2 (PHD2), cause erythrocytosis and in rare cases the development of neuroendocrine tumors. In the presence ...
Pfizer’s Hympavzi, given as a once-weekly subcutaneous injection using a pre-filled pen, works by reducing the amount of TFPI ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果